Hwail Pharm Executive Sin Dong-gu's Shareholding Decreases Due to Stock Split, Stake Unchanged at 0.03%

Hwail Pharm non-registered executive Sin Dong-gu reported a decrease in his common shares from 22,100 to 2,210 due to a stock split on April 9, 2026.
This change is a routine adjustment from the share consolidation, leaving his ownership percentage unchanged at 0.03%.
The filing is an individual insider share adjustment without any capital change or new funding for the company, and no external counterparty is involved.
[AI Summary]The reduction in Sin Dong-gu's shareholding at Hwail Pharm due to the stock split is a simple adjustment with negligible impact on shareholder value. As there is no change in capital structure or growth strategy, this event is assessed as neutral from an investment perspective.